Zhengye Biotechnology (ZYBT) Institutional Ownership $7.31 -1.09 (-12.98%) As of 02:12 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Zhengye Biotechnology (NASDAQ:ZYBT)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$393.46KNumber ofInstitutional Sellers(last 12 months)0 Get ZYBT Insider Trade Alerts Want to know when executives and insiders are buying or selling Zhengye Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Zhengye Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025Invesco Ltd.36,839$220K0.0%N/A0.078% 8/8/2025 Geode Capital Management LLC29,068$174K0.0%N/A0.062% (Data available from 1/1/2016 forward) ZYBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ZYBT shares? During the previous two years, the following institutional investors and hedge funds held shares of Zhengye Biotechnology shares: Invesco Ltd. ($220K), Geode Capital Management LLC ($174K).Learn more on Zhengye Biotechnology's institutional investors. Which institutional investors have been buying Zhengye Biotechnology's stock? The following institutional investors have purchased Zhengye Biotechnology's stock in the last 24 months: Invesco Ltd. ($36.84K), and Geode Capital Management LLC ($29.07K). How much institutional buying is happening at Zhengye Biotechnology? Institutional investors have bought a total of 65,907 shares in the last 24 months. This purchase volume represents approximately $393.46K in transactions. Related Companies ARDX Major Shareholders PRAX Major Shareholders AMPH Major Shareholders COLL Major Shareholders VERV Major Shareholders AKBA Major Shareholders RCUS Major Shareholders SYRE Major Shareholders GPCR Major Shareholders PROK Major Shareholders This page (NASDAQ:ZYBT) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zhengye Biotechnology Holding Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zhengye Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access